Companies Related to "Ivantis Announces Results Landmark Prospective Randomized Comparative MIGS" [Most Relevant Company Matches] RSS

13:15 EST 14th December 2018 | BioPortfolio

Here are the most relevant search results for "Ivantis Announces Results Landmark Prospective Randomized Comparative MIGS" found in our extensive corporate database of over 50,000 company records.

Showing "Ivantis Announces Results Landmark Prospective Randomized Comparative MIGS" Companies 1–25 of 1,200+

Extremely Relevant

Ivantis, Inc.

Ivantis, Inc. is a privately held company established in 2007 to design, develop and commercialize new technologies to treat eye disease. Investors include New Enterprise Associates and Delphi Ventures.


Ivantis Inc.

Ivantis, Inc. is a privately held company established in 2007 to design, develop and commercialize new technologies to treat eye disease. Investors include New Enterprise Associates, Delphi Ventures, and Ascension Health Ventures.

Landmark Health

Landmark is an industry leader of home-based medical care for patients with complex health needs, covering more than 70,000 lives. Its community-based, physician-led medical teams specialize in house calls and deliver medical, behavioral, social and palliative care to individuals with multiple chronic conditions wherever they reside, and whenever they need...

Celleration, Inc.

Celleration, Inc., a privately held medical device company, was founded in 1999 to develop and commercialize its therapeutic ultrasound platform. The patented MIST Technology delivers non-contact, low-frequency, low-intensity ultrasound to the patient's injured soft tissue in a painless fashion. The chronic diabetic foot ulcer market had been the Company's initial focus. MIST Therapy(R) has since ...

Landmark Mortgage Group

Landmark Mortgage Group is a mortgage banking firm specializing in residential lending with offices in Pleasanton, Livermore and Santa Cruz. Through the company's previous mortgage banking platform, the offices generated over $310 million in loan volume in 2009. Loan programs available through the direct lender include all conventional, jumbo, FHA, VA and reverse mortgage products. http://www.lmgl...

Tricida, Inc.

Tricida, Inc. is a pharmaceutical company focused on the development and commercialization of TRC101, a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with CKD. Metabolic acidosis is a condition commonly caused by CKD that is believed to accelerate the progression of kidney deterioration. Tricida has successfully...

Landmark Legal Foundation

Landmark Hospital Holdco LLC

European Randomized Study of Screening for Prostate Cancer (ERSPC)

ERSPC (European Randomized Study of Screening for Prostate Cancer)


Health outcomes aren't jeopardized when patients participate in randomized clinical trials of approved treatments, according to a new study. The results address misgivings some physicians have had about whether enrolling patients in a clinical trial might have a detrimental impact on their ability to receive individualized treatment. Conducted by a team led by Yale University's Dr. Cary P. Gross, ...

Cypress Bioscience

We are committed to being the innovator and leader in providing products for the treatment of patients with Functional Somatic Syndromes, such as Fibromyalgia Syndrome, or FMS, and other central nervous system disorders. Specifically, our strategy involves acquiring or in-licensing central nervous system, or CNS, active compounds and developing them for novel and typically underserved indications....

Adeona Pharmaceuticals, Inc.

Adeona (AMEX: AEN) is a pharmaceutical company developing new medicines for serious central nervous systems diseases. Adeona's primary strategy is to in-license clinical-stage drug candidates that have already demonstrated a certain level of clinical efficacy and develop them to an inflection point in valuation resulting in a significant development and marketing collaboration. Trimesta (estriol) ...

Prescription Dispensing Laboratories

Prescription Dispensing Laboratories announces a major discovery related to the use of calcium channel blockers for the noninvasive, topically applied transdermal treatment of Peyronie's Disease, Dupuytren's Contracture, Plantar Fibromatosis and related connective tissue disorders worldwide patents are pending). Accept no imitations. Transdermal verapamil is available only from PDLABS.A comparison...


The single-group, multi-dose study examined the ability of the Rx Guardian(SM) algorithm to differentiate among low, medium and high daily doses of OxyContin®. Oxycodone levels were detected in the urine of 36 healthy volunteers using a liquid chromatography-mass spectrometry (LC-MS-MS) assay. Participants were randomized to receive 80mg, 160mg or 240mg of daily OxyContin® to steady state cond...

Probably Relevant

Abt Associates

Abt Bio-Pharma Solutions, Inc. (ABS) provides integrated clinical, health economic, and commercialization services to the pharmaceutical, biotechnology, medical device, and diagnostics industries worldwide. The company specializes in demonstrating the value, safety, and efficacy of health technologies through prospective studies as well as through retrospective data analyses, models, and quantitat...

European Organisation for Research and Treatment of Cancer (EORTC)

The aims of the European Organisation for Research and Treatment of Cancer (EORTC) are to develop, conduct, coordinate, and stimulate laboratory and clinical research in Europe to improve the management of cancer and related problems by increasing survival but also patients’ quality of life. Extensive and comprehensive research in this wide field is often beyond the means of individualEuropean l...

Rigrodsky & Long, P.A.

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of BioClinica, Inc. (“BioClinica” or the “Company”) (NASDAQ GM: BIOC) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by J...

ESA Biosciences, Inc

ESA Biosciences, Inc. announces that the award-winning Corona™ Charged Aerosol Detector (CAD™) has been enhanced for greater compatibility with solvents used in industrial, chemical and polymer analyses.The Corona®-Plus Charged Aerosol Detector offers all-in-one performance benefits that refractive index (RI), low wavelength (UV), evaporative light scattering (ELS), and chemiluminescence nitr...

DSL Chemicals (Shanghai) Co., Ltd

Founded in 1997, DSL Chemicals (Shanghai) Co., Ltd. researches, manufactures, develops and sources a wide range of quality chemical compounds, primarily:aromatic organic intermediates intermediates for pesticides intermediates for pharmaceuticalsactive pharmaceutical ingredients (APIs)

Optherion, Inc.

Optherion, Inc. is a private, innovative biotechnology company that is developing protein therapeutics and molecular diagnostics for the management of dry and wet Age-related Macular Degeneration (AMD) and other chronic diseases involving the alternative complement system. Optherion's proprietary technologies are based on landmark scientific discoveries linking certain genes to AMD.

True Results

True Results, is America’s number one Lap Band provider, having completed more than 16,000 procedures. With an industry-leading network of physicians, healthcare professionals, surgical centers and aftercare specialists, True Results is dedicated to the comprehensive treatment and care of gastric banding patients. True Results’ aftercare program, ...

Jennerex Biotherapeutics

Jennerex is a clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The Company's lead product JX-594, currently in an international randomized Phase 2 clinical trial for patients with primary liver cancer, demonstrated promising Phase 1 efficacy and safety results in patients with a diverse a...

AccuScan Instruments Incorporated

AccuScan has been supplying quality biomedical research instrumentation for over 18 years - WorldWide.We have a standard line of successful products, but also like to handle special projects that are challenging and interesting. If you cannot locate it from another source, then you should be contacting us.AccuScan serves the following areas of science:•Neuro and Brain Sciences •Pharmacology ...


Biothera, a privately held U.S. biotechnology company, is developing Imprime PGG, a late clinical stage biologic that modulates the immune response to cancer. Data from the most recent randomized phase 2 study of Imprime PGG in first line non-squamous non-small cell lung cancer (NSCLC) was featured as a late-breaking abstract in the Immunotherapy of Cancer...

More From BioPortfolio on "Ivantis Announces Results Landmark Prospective Randomized Comparative MIGS"

Quick Search


Corporate Database Quicklinks